Much of the inbound flow reaches Indian hospitals through facilitators and agents paid a commission on the bill. That makes direct acquisition a channel conflict before it is a marketing problem: the hospital spends money to reach patients its own distribution is already paid to deliver, and an enquiry the hospital sourced can be claimed by an agent after the fact. No media plan resolves this. An attribution rule and a commercial position have to exist before the first campaign runs.
The enquiry comes from an adult child abroad, a spouse, a local facilitator or a referring doctor, and it arrives on WhatsApp rather than through a form, in the sender’s working hours rather than yours. Copy written to reassure a patient misses the person actually building the shortlist, and a contact route that assumes an Indian number and Indian office hours loses the enquiry before anyone opens a clinical page.
Who issues the invitation letter, how long the stay will be, whether an attendant can travel too, where they will sleep, what they will eat, who interprets, and how the money moves. These questions end more enquiries than any comparison of clinical capability, and almost no Indian hospital answers them in one place, in advance, in the language the family is asking in.
A family in Nairobi or Tashkent is weighing India against 2 or 3 other destinations on the number that matters to them: everything it will cost to arrive, be treated, stay and go home. A consultation fee answers none of that, and request a quote adds days to a decision the family is trying to make this week. The institution that publishes a banded estimate with its inclusions and exclusions named gets shortlisted by people who never contacted anybody at all.
The unit of planning is the source country. Nigeria, Oman, Bangladesh and Uzbekistan are 4 different businesses that happen to share a hospital, and a single International Patients page is the standard mistake in this category.
Specialty demand, price sensitivity, language, platform and payment route change completely across the map. Short-haul flow from Bangladesh arrives frequently, often overland, and is decided on total cost and on proximity to the border crossing. West and East African enquiries carry longer stays, larger tickets and an accompanying attendant, and are often researched inside Facebook groups and WhatsApp groups rather than on search. Gulf enquiries mix self-paying residents, expatriate workers and sponsored patients arriving through embassy or insurer panels. Central Asian and CIS enquiries need Russian, and often reach you on Telegram. Each source country gets its own landing estate, language, contact number and creative, because the only thing they share is the destination.
A banded estimate for the procedures you actually want, stating what sits inside the number and what does not: room category, expected days admitted, expected days in India after discharge, the attendant, follow-up review, and what moves the figure up or down. It is an estimate rather than a quotation and it says so plainly. This is the most requested and least published thing in the category, and putting it in public converts the family that was never going to fill in a form to find out.
One place that sets out what your hospital does and how it does it: how an invitation letter is requested and issued, how records are reviewed before travel, what airport pickup exists, which languages your interpreters actually cover, what accommodation sits within walking distance and at what nightly cost, what food is available, and how payment is accepted and in which currency. What that page does not do is give visa or immigration advice. Eligibility, categories, documentation and duration are matters for the relevant mission and for the authorities of both countries. Describe your own process, route the rest, and date the page.
A domestic patient walks in, looks around the ward and decides. An international patient cannot do any of that and is wiring a large sum to an institution in a country they have never entered. What replaces the visit is verifiable: accreditation stated plainly and checkable, NABH or JCI where you hold it, a named international patient coordinator with a face, a direct number and a stated language, a written step-by-step of what happens between the first message and discharge, and a response time measured in the sender’s time zone rather than yours. Trust in this category is built almost entirely from published process, because none of the usual local proof is available to the person deciding.
What works differs by market: language-specific search and maps in the Gulf, Facebook and YouTube in Bangladesh and across West Africa, Telegram and Russian-language content for Central Asia and the CIS, diaspora community media and clinic-adjacent NRI channels for families planning treatment around a visit home, empanelment with embassies, employers and insurers wherever sponsored flow exists, and WhatsApp as the surface every one of them converts on. What we do not run is broad English-language awareness bought from an India ad account against generic treatment in India terms, and we do not buy volume from international lead marketplaces. The first delivers clicks from people with no route to travel. The second resells the same enquiry to several hospitals at once, so you pay to enter a race decided by whoever replies first, and it teaches your desk to treat every enquiry as low value.
Every enquiry carries a source country and a channel from the first message onward, and the funnel is reported as steps rather than as a total: enquiry received, estimate issued, invitation letter issued, visa issued, flight booked, patient arrived. The 2 steps where this funnel leaks hardest, enquiry to visa issued and visa issued to arrived, are reported apart from each other and never blended, because they fail for unrelated reasons and only one of them is something marketing can act on.
The window between a first message and a patient landing in India runs for weeks and often for months, and the longest part of it belongs to nobody in your organisation. A family asks for an estimate, waits for it, asks what the total will be once stay and an attendant are included, compares that figure against 2 other countries, and then waits again on an appointment at a mission, on a document, on a flight and on a way to move a large sum across a border. Marketing owns the first 2 steps, the international desk owns the middle, and the enquiry is usually lost somewhere neither of them is watching. We plan the whole path as one funnel, publish the answers that stall it, and measure each step apart from the others so a drop is visible while it is still fixable.
Which countries send which procedures to you today, what they pay, where they research, and who they compare you against, established before any budget is committed.
A page set per source country in the working language with local contact routes, plus the entity and process content that gets your hospital named accurately when an assistant answers a which-hospital-in-India question.
Banded all-in estimates with inclusions, exclusions, expected length of stay and the variables that move the number, published rather than promised on a call.
The travel, stay, interpreter, attendant and payment answers, plus a named coordinator with a stated response time, written as your own process and kept clear of immigration advice.
NRI family programmes, and empanelment work with embassies, employers and insurers in the markets where sponsored and covered patients are placed rather than won.
Channel-separated enquiry routes, an agreed agent and direct attribution rule, and step-level reporting from first message to arrival, split by source country.
Success rates, survival figures and comparative efficacy claims are not available to a hospital advertising in India, and on top of that the advertising rules that bind a campaign are those of the country where the ad is served rather than the country the hospital sits in. Several source markets treat health advertising as a licensed activity with prior approval attached, some restrict what a provider outside the country may say at all, and testimonial and endorsement rules differ market to market. A creative cleared for one source country cannot be assumed compliant in the next, so each market is cleared on its own current rules before launch rather than on last year’s reading of them.
This is the most searched part of the journey and the part a hospital must not answer. You can describe your own documents and your own process: what an invitation letter is, how a patient requests one from your desk, what your team needs in order to issue it, and how long your side of that usually takes. You cannot advise on categories, eligibility, permitted duration, documentation or registration after arrival. Those rules sit with the relevant mission and with the authorities of both countries, they change without notice, and a page that gets them wrong causes real harm to a family and real exposure to the hospital.
Health status is a sensitive category, so customer lists, your own data segments and lookalikes built on a diagnosis are unavailable to you. Separately, targeting a country is not the same as reaching the people in it who can actually travel: cheap delivery in a large market produces enquiries with no route to India, language targeting collects the diaspora and the resident population together when they are different buyers with different budgets, and a location setting that includes people interested in a place will serve your Gulf campaign inside India. Payment currency, local disclosure requirements and account-level restrictions also differ per market, and platform policy moves without notice, so current policy is checked directly for each market before spend rather than assumed.
Facilitators are paid a share of the bill, so every patient your own marketing brings in removes revenue from a partner you rely on for volume, and every patient an agent claims after the fact removes the case for your marketing budget. This has to be settled commercially before it is settled operationally: a distinct number and enquiry route per channel, a first-contact rule written down and agreed with the desk, agent codes captured at the point of enquiry rather than reconstructed later from memory, and direct cost per arrival compared against the fully loaded commission cost rather than against zero. Without that, the direct channel loses an argument it should win.
Our healthcare work spans hospitals, clinics, home care, digital health and individual clinician brands, including Apollo Home Healthcare, Eye Care Live, prakruti.health, BJM Healthcare and Releaf Wellness. The cross-border programme we run is India patient acquisition for HELENE Clinic, Tokyo, which is this same problem in the opposite direction: a patient researching in one country, a provider in another, and a decision that only counts when somebody boards a plane.
upGrowth runs India patient acquisition for HELENE Clinic, Tokyo. An enquiry that starts in one country, has to survive language, distance, currency and a travel decision, and only becomes revenue when a person actually arrives, is work we do directly rather than describe.
A Dhaka plan and a Lagos plan share the hospital and nothing else: different specialties, different price sensitivity, different languages, different platforms and different payment routes. We build them as separate programmes with separate budgets and separate reporting. That is more work than one International Patients page and it is the only structure that matches how the demand behaves.
A family abroad shortlists a person before it shortlists a building, and a growing share of that shortlisting now happens inside AI assistants that name clinicians and institutions rather than pages. upGrowth works with Dr. Aditya Sarin, medical oncologist at Sir Ganga Ram Hospital, New Delhi, on exactly that kind of named, verifiable and attributable clinical visibility.
Cost per patient arrived, split by source country and by channel, with enquiry to visa issued and visa issued to arrived reported apart from each other, and agent-sourced arrivals held to the same standard as direct ones at their fully loaded cost. That frame is agreed with you before launch rather than assembled afterwards to explain a quiet quarter.
The metric is cost per international patient arrived, split by source country and by channel. Cost per lead is not merely uninformative in this category, it points spend in the wrong direction, because the cheapest enquiries come from the markets with the widest gap between interest and a boarding pass. A desk can report a falling cost per lead across a quarter in which fewer patients landed than in the quarter before it.
Underneath the arrival number, 2 conversion steps have to be reported separately and never blended: enquiry to visa issued, and visa issued to arrived. They fail for unrelated reasons. The first fails on estimates that were never sent, invitation letters that took a week, logistics questions nobody answered, and a coordinator who replied the next working day to a message sent overnight. The second fails on money, on flights, on a relative who could not get leave, and sometimes on a patient who became too unwell to travel. Only the first is a marketing problem, and blending the 2 hides it.
The rest is a handover problem, and it is the same one every hospital has, just more expensive here. An enquiry lands on WhatsApp at 2am India time from a number nobody recognises, with a photograph of a discharge summary and no name attached. Whether it becomes an arrival depends on who picks it up, how quickly, in which language, and whether the international desk and the marketing team are looking at the same list. We set out how that gap opens in Pain in the Handover, our field note on why hospital enquiries die between the message and the appointment.
The operating detail sits in the international patient acquisition playbook, a free PDF from our healthcare programme.